|
|
 |
YOU ARE HERE > |
Home > The
Medicare Monthly Review >
|
|
Content Section
Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material which is copyrighted by the American Medical Association (AMA). You are forbidden to download the files unless you read, agree to and abide by the provisions of the copyright statement. Read the copyright statement now (you will be linked back to here).
|
 |
National
Government Services, Inc.
Medicare Monthly Review Part A and B |
|
A
Combined Part A and Part B Newsletter |
MMR-2007 12A, December 2007
Retired Local Coverage Determinations (LCDs), November 30, 2007
As part of the current consolidation of LCDs within National Government Services Medicare contracts, National Government Services Part A - New York will retire the Local Coverage Determinations (LCDs) listed below, effective November 30, 2007. These retired LCDs will be superseded by the consolidated LCDs listed in the last column, effective December 1, 2007.
Part A New York LCDs Being Retired 11/30/2007 |
LCD Number |
National Government Services LCDs Superseding Part A New York LCDs - Effective 12/01/2007 |
Aloxi (Palenosetron Hydrochloride) |
L17580 |
Drugs and Biologicals, Coverage of, for Label and Off-Label Uses - L25820 |
Aranesp (Darbepoetin Alfa) for ESRD Use |
L19140 |
Erythropoietin Stimulating Agents(ESA) - L25211 |
Beta Glucocerebrosidase and Analogues |
L2206 |
Drugs and Biologicals, Coverage of, for Label and Off-Label Uses - L25820 |
CT Colonography (Virtual Colonoscopy) |
L17586 |
Computed Tomographic (CT) Colonography - L25233 |
Erythropoietin (Epoetin Alpha, EPO) for ESRD Use |
L13700 |
Erythropoietin Stimulating Agents(ESA) - L25211 |
Fluorescein Angiography - |
L2170 |
Ophthalmic Angiography (Fluorescein and Indocyanine Green) - L25347 |
Human Skin Equivalent |
L22620 |
Biologic Products for Wound Treatment and Surgical Interventions - L26003 |
Hyaluronase Polymers |
L671 |
Drugs and Biologicals, Coverage of, for Label and Off-Label Uses - L25820 |
Magnetic Resonance Angiography |
L513 |
Magnetic Resonance Angiography (MRA) - L25367 |
Sclerotherapy for Varicose Veins of the Lower Extremities with or without Doppler/Duplex Guidance |
L659 |
Varicose Veins of the Lower Extremity, Treatment of - L25519 |
Zoledronic Acid |
L690 |
Drugs and Biologicals, Coverage of, for Label and Off-Label Uses - L25820 |
|
Note  : Links with this graphic go to an external site outside of Empire Medicare Services and will open in a new window. |
Note  : You must have the Adobe Acrobat Reader (version 4.0 or higher) to view the PDF files. If you do not already have this software, you can (This software is free!). |
Note  : PDF file links externally and will open in a new window. You must have the Adobe Acrobat Reader (version 4.0 or higher) to view the PDF files. If you do not already have this software, you can (This software is free!).
|
Note  : You must have WinZip to view the files. If you do not already have this software, you may download an evaluation version from: . |
|
